Physiopathology of Behavioral Addictions and Biomarkers (MiRACle)
Physiopathology of Behavioral Addictions and Biomarkers: microRNAs Implication - MiRACle : a Pilot Study.
The goal of this observational study is to evaluate the expression of miR-10a-5p in the blood in patients with sexual addiction or food addiction. The main question it aims to answer is : To determine whether adults patients with SA or FA exhibit a distinct blood miR-10a-5p expression profile compared with matched healthy controls.
For all participants, one blood sample will be collected.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Pr Caroline Victorri-Vigneau
- Phone Number: 02.40.84.76.20
- Email: marie.bronnec@chu-nantes.fr
Study Locations
-
-
-
Nantes, France
- Nantes University Hospital
-
Contact:
- Gaëlle CHALLET
- Phone Number: 02.40.84.76.20
- Email: gaelle.bouju@chu-nantes.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with food or sexual addiction, compared with age- and sex-matched healthy controls with no current addictive disorder.
Description
Inclusion criteria
For patients with FA:
- Male and females ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of FA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with FA:
- Male and females ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For patients with SA:
- Male ≥ 18 years old
- Already in care or newly initiating care
- Participating to EVALADD cohort
- Current diagnosis of SA
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
For healthy controls matched to patients with SA:
- Male ≥ 18 years old
- Oral consent provided
- Affiliated with French social security system or beneficiary from such system
Exclusion Criteria :
For patients with FA:
- Presence of a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For patients with SA:
- Presence of a current diagnosis of FA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
For healthy controls:
- Without a current diagnosis of FA
- Without a current diagnosis of SA
- Presence of any current addictive disorder (substance [except tobacco] use disorders, gambling disorder, gaming disorder)
- Presence of any current instable psychiatric disorder (requiring the initiation or adapation of medication)
- Pregnancy or breastfeeding woman
- Trusteeship or curatorship
- Major cognitive impairment
- Not fluent in French
Study Plan
How is the study designed?
Design Details
- Observational Models: CASE_CONTROL
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Patients with addiction
Patients with food addiction (FA) or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
|
Healthy controls
Healthy controls matched on sex and age to patients with food addiction or sexual addiction |
One blood sample wiil be collected into a 10mL K2EDTA BD Vacutainer® tube |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood miR-10a-5p expression
Time Frame: 3 months
|
The concentration of each miR-enriched fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood additional circulating miRs expression
Time Frame: 3 months
|
The concentration of circulating miRs fraction will be determined by spectrophotometric between patients with SA or FA and matched healthy controls. |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and age |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and sex |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and duration of addiction |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and severity of addiction |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and tobacco-use |
3 months
|
|
Clinical Characteristics
Time Frame: 3 months
|
Association between blood expression levels of circulating miRs and psychiatric disorders |
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Sexual Dysfunctions, Psychological
- Behavior, Addictive
- Compulsive Behavior
- Impulsive Behavior
- Feeding and Eating Disorders
- Sexual and Gender Disorders
- Behavior
- Food Addiction
- Compulsive Sexual Behavior Disorder
- Investigative Techniques
- Specimen Handling
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Punctures
- Surgical Procedures, Operative
- Blood Specimen Collection
Other Study ID Numbers
Other Study ID Numbers
- RC26_0091
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.